Stonehage Fleming (UK)’s Edwards Lifesciences EW Stock Holding History

Stonehage Fleming (UK)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$628K	Hold	23,868	–	–	0.29%	99
2015 Q3	$565K	Hold	23,868	–	–	0.27%	101
2015 Q2	$567K	Hold	23,868	–	–	0.26%	99
2015 Q1	$567K	Buy	+23,868	New	+$535K	0.26%	97
2014 Q4	–	Sell	-156,348	Closed	-$2.66M	–	309
2014 Q3	$2.66M	Buy	156,348 +121,800	+353%	+$1.92M	1.19%	13
2014 Q2	$494K	Buy	+34,548	New	+$468K	0.2%	105

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Stonehage Fleming (UK)'s EW Position: Q4 2015 in Review

Stonehage Fleming (UK) held its Edwards Lifesciences (EW) position steady in Q4 2015 at 23,868 shares worth $628K. The position accounts for 0.29% of the portfolio, ranked #99.

Stonehage Fleming (UK) first reported a position in EW in Q2 2014 and has held it in 6 quarters since. The position peaked at $2.66M in Q3 2014. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

Stonehage Fleming (UK) held 23,868 shares of Edwards Lifesciences worth $628K as of Q4 2015.
Stonehage Fleming (UK) left its Edwards Lifesciences share count unchanged in Q4 2015.
Edwards Lifesciences made up 0.29% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #99 holding.
Stonehage Fleming (UK) first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 6 quarters since.
Stonehage Fleming (UK)'s Edwards Lifesciences position peaked at $2.66M in Q3 2014.
605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.